NPI: 1548205883 · PLANT CITY, FL 33563 · Obstetrics & Gynecology Physician · NPI assigned 06/19/2006
Authorized official GORKEN, LYNDA controls 20+ related entities in our dataset. Read more
| Authorized Official | GORKEN, LYNDA (VICE PRESIDENT, PFS DIVISION) |
| NPI Enumeration Date | 06/19/2006 |
Other providers sharing the same authorized official: GORKEN, LYNDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 34,395 | $490K |
| 2019 | 97,641 | $2.71M |
| 2020 | 80,746 | $2.02M |
| 2021 | 85,578 | $2.34M |
| 2022 | 74,662 | $2.80M |
| 2023 | 37,178 | $1.70M |
| 2024 | 16,468 | $782K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 22,751 | 20,722 | $2.13M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 23,077 | 18,548 | $1.73M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 20,622 | 4,396 | $1.63M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 11,638 | 2,623 | $938K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10,996 | 8,499 | $730K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 11,294 | 2,547 | $644K |
| 80053 | Comprehensive metabolic panel | 19,519 | 15,439 | $553K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,096 | 2,751 | $479K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,394 | 3,167 | $303K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,370 | 2,656 | $251K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,846 | 3,203 | $239K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,280 | 3,650 | $213K |
| 59899 | 1,242 | 966 | $182K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,967 | 4,873 | $173K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,711 | 1,843 | $149K |
| 81003 | 16,373 | 14,094 | $130K | |
| 97803 | 1,047 | 995 | $121K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,183 | 1,000 | $109K |
| 87631 | 1,568 | 1,451 | $96K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 149 | 133 | $94K |
| 41899 | Unlisted procedure, dentoalveolar structures | 239 | 203 | $89K |
| 59025 | Fetal non-stress test | 811 | 633 | $85K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,606 | 2,323 | $83K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,899 | 1,596 | $83K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,589 | 2,319 | $82K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,632 | 1,083 | $71K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,371 | 1,558 | $70K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 727 | 684 | $69K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5,172 | 4,847 | $63K |
| 36415 | Collection of venous blood by venipuncture | 27,732 | 17,404 | $61K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1,896 | 1,807 | $58K |
| G0378 | Hospital observation service, per hour | 7,476 | 3,094 | $55K |
| 97161 | 721 | 636 | $53K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3,821 | 1,154 | $53K |
| 97162 | 402 | 375 | $50K | |
| 97802 | 340 | 333 | $44K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 976 | 919 | $38K |
| 81025 | 2,026 | 1,819 | $37K | |
| 92526 | 543 | 178 | $33K | |
| 71046 | Radiologic examination, chest; 2 views | 3,807 | 3,408 | $33K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,220 | 1,122 | $32K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 27,646 | 19,907 | $30K |
| 87641 | 541 | 486 | $30K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 661 | 618 | $30K |
| 92523 | 268 | 253 | $30K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,943 | 1,495 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,875 | 1,578 | $24K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 715 | 577 | $23K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4,114 | 3,913 | $22K |
| 82948 | 6,856 | 2,370 | $22K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 950 | 860 | $21K |
| 71045 | Radiologic examination, chest; single view | 8,548 | 7,218 | $18K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,145 | 2,692 | $17K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 372 | 342 | $17K |
| 73630 | 372 | 341 | $14K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 172 | 143 | $14K |
| 97167 | 111 | 111 | $13K | |
| 97163 | 125 | 110 | $13K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 651 | 464 | $12K |
| 73130 | 290 | 262 | $12K | |
| J7050 | Infusion, normal saline solution, 250 cc | 662 | 381 | $12K |
| 84702 | 1,988 | 1,542 | $12K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 227 | 216 | $11K |
| 0100U | 214 | 187 | $11K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 12,239 | 9,051 | $11K |
| 73564 | 246 | 214 | $11K | |
| 73610 | 278 | 257 | $10K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,036 | 881 | $10K |
| 84484 | 7,921 | 4,361 | $9K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,811 | 1,676 | $9K |
| 97750 | 198 | 160 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,199 | 1,701 | $8K |
| A9270 | Non-covered item or service | 2,233 | 775 | $8K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,552 | 3,672 | $8K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 6,036 | 4,708 | $7K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 189 | 173 | $7K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 35 | 13 | $7K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,885 | 2,405 | $6K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,458 | 2,054 | $6K |
| 76801 | 1,317 | 1,123 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 8,482 | 7,018 | $6K |
| 83880 | 2,357 | 1,819 | $6K | |
| 86900 | 1,594 | 1,375 | $5K | |
| 93971 | 304 | 265 | $5K | |
| 96367 | 201 | 135 | $5K | |
| 80061 | Lipid panel | 1,214 | 934 | $5K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 2,211 | 1,879 | $5K |
| 84703 | 5,878 | 5,102 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,830 | 1,695 | $3K |
| 83735 | 2,953 | 1,981 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,510 | 2,010 | $3K |
| 97014 | 63 | 25 | $3K | |
| 85610 | 2,809 | 2,147 | $3K | |
| 76830 | Ultrasound, transvaginal | 655 | 608 | $3K |
| 87077 | 1,459 | 1,226 | $3K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 138 | 125 | $3K |
| 87186 | 1,230 | 1,029 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 148 | 127 | $2K |
| 73030 | 213 | 173 | $2K | |
| 85730 | 1,651 | 1,328 | $2K | |
| J3490 | Unclassified drugs | 848 | 766 | $2K |
| 87040 | 1,483 | 1,187 | $2K | |
| 83690 | 4,557 | 3,897 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,536 | 1,026 | $2K |
| 93970 | 75 | 62 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 985 | 748 | $2K |
| J1815 | Injection, insulin, per 5 units | 989 | 509 | $2K |
| J1650 | Injection, enoxaparin sodium, 10 mg | 209 | 77 | $2K |
| 85027 | 1,762 | 1,225 | $2K | |
| 85380 | 655 | 557 | $2K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 29 | 12 | $1K |
| 73110 | 15 | 13 | $1K | |
| 87660 | 1,592 | 1,482 | $1K | |
| 87510 | 1,589 | 1,479 | $1K | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 49 | 46 | $1K |
| 97116 | 27 | 12 | $1K | |
| 83605 | 1,194 | 896 | $1K | |
| 87480 | 1,590 | 1,478 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | 775 | 603 | $1K |
| J1644 | Injection, heparin sodium, per 1000 units | 779 | 204 | $1K |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 45 | 43 | $1K |
| 74018 | 90 | 81 | $987.79 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 34 | 28 | $883.32 |
| 72100 | 56 | 41 | $852.72 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 416 | 322 | $766.83 |
| 71250 | 30 | 25 | $720.14 | |
| 72040 | 13 | 13 | $715.29 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,001 | 3,263 | $708.23 |
| 84145 | 364 | 292 | $708.01 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 192 | 146 | $683.22 |
| 86901 | 1,570 | 1,351 | $602.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 638 | 596 | $568.82 |
| 87581 | 638 | 596 | $558.61 | |
| 87486 | 637 | 595 | $558.61 | |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 344 | 177 | $480.72 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,929 | 1,457 | $466.52 |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,448 | 1,222 | $415.95 |
| 73090 | 12 | 12 | $388.28 | |
| 96376 | 196 | 124 | $385.83 | |
| 70486 | 14 | 13 | $371.22 | |
| 12011 | 15 | 14 | $327.86 | |
| 76642 | 14 | 14 | $286.95 | |
| 86850 | 193 | 150 | $227.91 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 127 | 75 | $212.55 |
| 84100 | 247 | 141 | $207.19 | |
| 73560 | 17 | 12 | $173.28 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2,038 | 1,855 | $168.69 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 468 | 413 | $159.09 |
| 83036 | Hemoglobin; glycosylated (A1C) | 335 | 255 | $137.32 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 32 | 28 | $129.16 |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 207 | 170 | $90.54 |
| 87640 | 366 | 335 | $69.59 | |
| 0240U | 99 | 79 | $69.59 | |
| 73502 | 16 | 13 | $69.05 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 14 | 14 | $56.11 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 108 | 98 | $46.63 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,440 | 1,189 | $46.15 |
| C9113 | Injection, pantoprazole sodium, per vial | 17 | 14 | $40.39 |
| J2060 | Injection, lorazepam, 2 mg | 150 | 117 | $29.12 |
| 90715 | 31 | 26 | $23.90 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 31 | 25 | $23.90 |
| 82150 | 46 | 37 | $12.21 | |
| 87430 | 27 | 26 | $8.88 | |
| 90686 | 21 | 15 | $7.28 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 25 | 24 | $2.70 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 112 | 66 | $1.11 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 55 | 53 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 106 | 104 | $0.00 |
| 0353U | 32 | 29 | $0.00 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 15 | 14 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 22 | 13 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 331 | 285 | $0.00 |
| 87205 | 31 | 26 | $0.00 | |
| 82550 | 68 | 42 | $0.00 | |
| 87070 | 14 | 12 | $0.00 | |
| 86140 | 62 | 32 | $0.00 | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 121 | 108 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 22 | 15 | $0.00 |
| 82077 | 31 | 26 | $0.00 | |
| 81001 | 14 | 13 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 19 | 13 | $0.00 |
| 87340 | 16 | 13 | $0.00 |